TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/2/21 17:12  | 12/1/21  | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | De Backer Marianne | CA | D | P | 13 | 11.57 | 0 | 1 | 72 | 3 | D | |||||||||||||||
8/24/21 19:24  | 8/20/21  | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | De Backer Marianne | CA | D | P | 20 | 19.57 | 0 | 1 | 167 | 2 | D | |||||||||||||||
6/1/21 16:08  | 5/28/21  | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | De Backer Marianne | CA | D | P | 15 | 25.01 | 0 | 1 | New | 1 | D | |||||||||||||||
10/26/20 18:02  | 10/8/20  | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | De Backer Marianne | CA | D | P | 50 | 50.47 | 0 | 1 | 6 | 18 | D | |||||||||||||||
6/24/20 18:10  | 1/13/20  | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | De Backer Marianne | CA | D | P.m | 134 | 33.56 | 0 | 4 | 32 | 17 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |